Suchergebnisse - "Kazandjian, Dickran"

PubPharm (10)

1

Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma : pooled analysis of four single-arm studies

enthalten in: Leukemia & lymphoma | 2022

von Landgren, O. | Kazandjian, D. | Roussel, M. | +7

2

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma : A Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2021

von Kazandjian, D. | Hill, E. | Dew, A. | +31

3

Treatments for newly diagnosed multiple myeloma : when endurance is interrupted

enthalten in: The Lancet. Oncology | 2020

von Landgren, O. | Siegel, D. | Kazandjian, D. | +2

CommentOn: Lancet Oncol. 2020 Oct;21(10):1317-1330. - PMID 32866432

4

The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!

enthalten in: Best practice & research. Clinical haematology | 2020

von Kazandjian, D. | Dew, A. | Hill, E.

5

Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide

enthalten in: Scientific reports | 2019

von Huang, P. | Beedie, S. | Chau, C. | +7

6

Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone : Five-Year Follow-up of a Phase 2 Clinical Trial

enthalten in: JAMA oncology | 2018

von Kazandjian, D. | Korde, N. | Mailankody, S. | +4

7

Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

enthalten in: Bone marrow transplantation | 2018

von Tageja, N. | Korde, N. | Kazandjian, D. | +10

8

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Sissung, T. | Peer, C. | Korde, N. | +5

9

Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone

enthalten in: Leukemia & lymphoma | 2017

von Manasanch, E. | de Larrea, C. | Zingone, A. | +21

CommentIn: Leuk Lymphoma. 2017 Mar;58(3):513-515. - PMID 28093000

10

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

enthalten in: JAMA oncology | 2015

von Korde, N. | Roschewski, M. | Zingone, A. | +36

CommentIn: JAMA Oncol. 2015 Sep;1(6):754-5. - PMID 26181637

1
[1]